Today's episode of Redefining Medicine features Philip Werschler, MD, an internationally recognized expert in both medical and cosmetic dermatology/aesthetic surgery. One of the original Botox FDA investigators, Dr. Werschler has participated in numerous clinical trials throughout his career, in addition to assisting in the development of many drugs and devices. With extensive clinical experience and a history in academia, Dr. Werschler has also contributed to numerous studies, lectures, and publications in the field of dermatology, and is the founding aesthetic editor of the Journal of Clinical and Aesthetic Dermatology. He has been an active teaching member of the University of Washington faculty for over two decades, and currently serves as founding member and clinician of Spokane Dermatology Clinic and Werschler Aesthetics.